Immune Pharmaceuticals Profile

Performance

   

Odds of Distress

82%82%
Check how we calculate scores
Equity ratings for Immune Pharmaceuticals are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting June 18, 2019 and ending today September 16, 2019. Click here to learn more.
Immune Pharmaceuticals cannot be verified against its exchange. It appears that Immune Pharmaceuticals is not available for investing at the moment. Please verify the symbol is currently traded on BATS Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refesh

Immune Pharmaceuticals Key Fundamentals

Immune Pharmaceuticals Against Markets

Immune Pharmaceuticals cannot be verified against its exchange. It appears that Immune Pharmaceuticals is not available for investing at the moment. Please verify the symbol is currently traded on BATS Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refesh

Try Other Stock Suggestions

Immune Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, engages in the development of various therapeutic agents for the treatment of immunologic and inflammatory diseases. Immune Pharmaceuticals, Inc. was founded in 2010 and is based in Fort Lee, New Jersey. Immune Pharmaceuticals operates under Drug Manufacturers - Major classification in USA and is traded on BATS Exchange. It employs 7 people.. The public information regarding Immune Pharmaceuticals's current market price is not available at this time.
NameImmune Pharmaceuticals
Chairman of the Board, CEODaniel TeperView All
Analyst Consensus
Macroaxis Advice
Specialization
Healthcare, Pharmaceuticals And Biosciences
InstrumentUSA Stock View All
Business Address1 Bridge Plaza North
ExchangeBATS Exchange
ISINUS45254C2008
SectorHealthcare
IndustryDrug Manufacturers - Major
BenchmarkDOW
Websitewww.immunepharma.com
Phone201 464 2677
CurrencyUSD - US Dollar

Immune Pharmaceuticals Corporate Directors

Cameron Durrant Independent Director
John Neczesny Independent Director
Jeffrey Paley Independent Director
See also Risk vs Return Analysis. Please also try Focused Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Search macroaxis.com